Changes in the activity of lysosomal enzymes in rat kidneys in the course of acute pancreatitis
Halina Łąkowska, Ryszard Maciejewski, Piotr Szkodziak, Grzegorz StaśkiewiczMed Sci Monit 2001; 7(6): BR1193-1197 :: ID: 508037
Abstract
Background: The pathogenesis of complications of acute pancreatitis is an important subject of research for many experimenters. The aim of the research reported here was to evaluate changes in the activity of lysosomal enzymes in rat kidneys in the course of experimentally-induced acute pancreatitis.
Material and methods: 70 male Wistar rats of reproductive age with a mean body weight of 300 g were included in the study. Healthy animals were used as a control group to determine normal values for the activity of renal lysosomal enzymes: Cathepsin B, D, L, Acid Phosphatase, N-acetyl-beta-D-glucosaminidase, Lipase, Sulfatase, and Beta-D-Galactosidase. Acute pancreatitis was induced by injecting a 5% solution of sodium taurocholate into the hepatopancreatic duct. The animals were divided into 3 groups: I – healthy rats – normal group; II – rats with acute pancreatitis evoked by the injection of 5% sodium taurocholate; III – rats with a 0.9% solution of natrium chloride injected into the hepatopancreatic duct. Groups II and III were randomly divided into 6 subgroups. At 2, 6, 12, 24, 48, and 72 hours after the induction of acute pancreatitis the rats were anesthetized and their kidneys used for biochemical investigations.
Results: The differences in enzyme activity were statistically significant among the various subgroups of Groups II and III groups. The highest decrease in enzyme activity was found between 12 and 48 hours after the induction of the disease, followed by small increases up to 72 hours.
Conclusion: The monitoring of lysosomal enzyme activity can be used to evaluate the increase of kidney failure in the course of experimentally-induced acute pancreatitis.
Keywords: acute pancreatitis, Kidney, Lysosomal enzymes, Rat
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952